Toni K. Choueiri, MD
Principal Investigator
Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology and the Medical Director of Strategic International Initiatives at Dana-Farber Cancer Institute, co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.
As a medical oncologist, clinical trialist and translational researcher, Dr. Choueiri specializes in the treatment of Genitourinary Cancers (prostate, bladder, prostate, testis and kidney cancer) with a focus on kidney cancer. His research has been published nationally and internationally, with more than 800 articles in dozens of peer-reviewed journals, leading to new drugs, and important advances in the treatment of genitourinary cancers.
As a medical oncologist, clinical trialist and translational researcher, Dr. Choueiri specializes in the treatment of Genitourinary Cancers (prostate, bladder, prostate, testis and kidney cancer) with a focus on kidney cancer. His research has been published nationally and internationally, with more than 800 articles in dozens of peer-reviewed journals, leading to new drugs, and important advances in the treatment of genitourinary cancers.